img

Global Polyvalent Streptococcus Pneumococcal Vaccines Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Polyvalent Streptococcus Pneumococcal Vaccines Market Insights, Forecast to 2034

The polyvalent streptococcus pneumoniae vaccine is a vaccine that mainly prevents pneumonia caused by Streptococcus pneumoniae. It contains a variety of serotypes that often cause streptococcus pneumoniae infection. After vaccination, it can effectively reduce the risk of pneumonia infection.
Global Polyvalent Streptococcus Pneumococcal Vaccines market is expected to reach to US$ 6722 million in 2024, with a positive growth of %, compared with US$ 6615.9 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Polyvalent Streptococcus Pneumococcal Vaccines industry is evaluated to reach US$ 8609 million in 2029. The CAGR will be 4.2% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Pneumococcal vaccination protects against pneumococcus. Streptococcus pneumoniae causes them. The pneumococcal vaccine protects against sepsis, meningitis, and pneumonia. The main types are polysaccharide vaccines and conjugate vaccines. The drug is delivered by injection into the muscle or skin. The World Health Organization recommends routine vaccination of children and newborns with conjugate vaccines. The global pneumococcal vaccines market is expected to grow owing to increased development of new drugs and public, private, and regional efforts to educate the public about pneumococcal diseases and prevention. Regional immunization programs in many countries provide free pneumococcal vaccines to newborns and children throughout the year, pneumococcal vaccination services provide free vaccinations to anyone over the age of 65, and regional population health and safety organizations promote mass pneumococcal vaccination plan.
Report Covers
This report presents an overview of global Polyvalent Streptococcus Pneumococcal Vaccines market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Polyvalent Streptococcus Pneumococcal Vaccines market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithKline
Merck
Panacea Biotec
Pfizer
Pnuvax Incorporated
Serum Institute
Shinogi
Shenzhen Kangtai Biological Products
SK Bioscience
Walvax Biotechnology
Eli Lilly
Abera
Sanofi
Genentech
Segment by Type
9-Valent
13-Valent
23-Valent
Others

Segment by Application


Hospital
Community Clinics
Public Health Agencies
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Polyvalent Streptococcus Pneumococcal Vaccines plant distribution, commercial date of Polyvalent Streptococcus Pneumococcal Vaccines, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Polyvalent Streptococcus Pneumococcal Vaccines introduction, etc. Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Polyvalent Streptococcus Pneumococcal Vaccines
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Polyvalent Streptococcus Pneumococcal Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 9-Valent
1.2.3 13-Valent
1.2.4 23-Valent
1.2.5 Others
1.3 Market by Application
1.3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Community Clinics
1.3.4 Public Health Agencies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Estimates and Forecasts 2018-2029
2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region
2.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2018-2024)
2.2.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2024-2029)
2.2.4 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Region (2018-2029)
2.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Estimates and Forecasts 2018-2029
2.4 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region
2.4.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2018-2024)
2.4.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2024-2029)
2.4.4 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Manufacturers
3.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Manufacturers (2018-2024)
3.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines in 2022
3.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Manufacturers
3.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Polyvalent Streptococcus Pneumococcal Vaccines Revenue in 2022
3.3 Global Key Players of Polyvalent Streptococcus Pneumococcal Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type
4.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Historical Sales by Type (2018-2024)
4.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecasted Sales by Type (2024-2029)
4.1.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type
4.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecasted Revenue by Type (2024-2029)
4.2.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Price by Type
4.3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Price by Type (2018-2024)
4.3.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application
5.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Historical Sales by Application (2018-2024)
5.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecasted Sales by Application (2024-2029)
5.1.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application
5.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecasted Revenue by Application (2024-2029)
5.2.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Price by Application
5.3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Price by Application (2018-2024)
5.3.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Type
6.1.1 US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2029)
6.1.2 US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2018-2029)
6.2 US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Application
6.2.1 US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2029)
6.2.2 US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2018-2029)
6.3 US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Country
6.3.1 US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2029)
6.3.3 US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Type
7.1.1 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2029)
7.1.2 Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2018-2029)
7.2 Europe Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Application
7.2.1 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2029)
7.2.2 Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2018-2029)
7.3 Europe Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Country
7.3.1 Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2029)
7.3.3 Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Polyvalent Streptococcus Pneumococcal Vaccines Market Size
8.1.1 China Polyvalent Streptococcus Pneumococcal Vaccines Sales (2018-2029)
8.1.2 China Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029)
8.2 China Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Application
8.2.1 China Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2029)
8.2.2 China Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Type
9.1.1 Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2029)
9.1.2 Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2018-2029)
9.2 Asia Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Application
9.2.1 Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2029)
9.2.2 Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2018-2029)
9.3 Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region
9.3.1 Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2018-2029)
9.3.3 Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Merck Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Panacea Biotec
11.3.1 Panacea Biotec Company Information
11.3.2 Panacea Biotec Overview
11.3.3 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Panacea Biotec Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Pnuvax Incorporated
11.5.1 Pnuvax Incorporated Company Information
11.5.2 Pnuvax Incorporated Overview
11.5.3 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pnuvax Incorporated Recent Developments
11.6 Serum Institute
11.6.1 Serum Institute Company Information
11.6.2 Serum Institute Overview
11.6.3 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Serum Institute Recent Developments
11.7 Shinogi
11.7.1 Shinogi Company Information
11.7.2 Shinogi Overview
11.7.3 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shinogi Recent Developments
11.8 Shenzhen Kangtai Biological Products
11.8.1 Shenzhen Kangtai Biological Products Company Information
11.8.2 Shenzhen Kangtai Biological Products Overview
11.8.3 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Shenzhen Kangtai Biological Products Recent Developments
11.9 SK Bioscience
11.9.1 SK Bioscience Company Information
11.9.2 SK Bioscience Overview
11.9.3 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 SK Bioscience Recent Developments
11.10 Walvax Biotechnology
11.10.1 Walvax Biotechnology Company Information
11.10.2 Walvax Biotechnology Overview
11.10.3 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Walvax Biotechnology Recent Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Company Information
11.11.2 Eli Lilly Overview
11.11.3 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Eli Lilly Recent Developments
11.12 Abera
11.12.1 Abera Company Information
11.12.2 Abera Overview
11.12.3 Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Abera Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Abera Recent Developments
11.13 Sanofi
11.13.1 Sanofi Company Information
11.13.2 Sanofi Overview
11.13.3 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sanofi Recent Developments
11.14 Genentech
11.14.1 Genentech Company Information
11.14.2 Genentech Overview
11.14.3 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Genentech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Polyvalent Streptococcus Pneumococcal Vaccines Industry Chain Analysis
12.2 Polyvalent Streptococcus Pneumococcal Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Polyvalent Streptococcus Pneumococcal Vaccines Production Mode & Process
12.4 Polyvalent Streptococcus Pneumococcal Vaccines Sales and Marketing
12.4.1 Polyvalent Streptococcus Pneumococcal Vaccines Sales Channels
12.4.2 Polyvalent Streptococcus Pneumococcal Vaccines Distributors
12.5 Polyvalent Streptococcus Pneumococcal Vaccines Customers
13 Market Dynamics
13.1 Polyvalent Streptococcus Pneumococcal Vaccines Industry Trends
13.2 Polyvalent Streptococcus Pneumococcal Vaccines Market Drivers
13.3 Polyvalent Streptococcus Pneumococcal Vaccines Market Challenges
13.4 Polyvalent Streptococcus Pneumococcal Vaccines Market Restraints
14 Key Findings in The Global Polyvalent Streptococcus Pneumococcal Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 9-Valent
Table 3. Major Manufacturers of 13-Valent
Table 4. Major Manufacturers of 23-Valent
Table 5. Major Manufacturers of Others
Table 6. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Region (2018-2024)
Table 11. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Region (2024-2029)
Table 12. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2018-2024) & (K Units)
Table 14. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2024-2029) & (K Units)
Table 15. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Region (2018-2024)
Table 16. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Region (2024-2029)
Table 17. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Share by Manufacturers (2018-2024)
Table 19. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Polyvalent Streptococcus Pneumococcal Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Polyvalent Streptococcus Pneumococcal Vaccines Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Polyvalent Streptococcus Pneumococcal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Polyvalent Streptococcus Pneumococcal Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polyvalent Streptococcus Pneumococcal Vaccines as of 2022)
Table 25. Global Key Manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines, Product Offered and Application
Table 27. Global Key Manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2024) & (K Units)
Table 30. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2024-2029) & (K Units)
Table 31. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Share by Type (2018-2024)
Table 32. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Share by Type (2024-2029)
Table 33. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Type (2018-2024)
Table 36. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Type (2024-2029)
Table 37. Polyvalent Streptococcus Pneumococcal Vaccines Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Polyvalent Streptococcus Pneumococcal Vaccines Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2024) & (K Units)
Table 40. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2024-2029) & (K Units)
Table 41. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Share by Application (2018-2024)
Table 42. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Share by Application (2024-2029)
Table 43. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Application (2018-2024)
Table 46. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Application (2024-2029)
Table 47. Polyvalent Streptococcus Pneumococcal Vaccines Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Polyvalent Streptococcus Pneumococcal Vaccines Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2024-2029) & (K Units)
Table 62. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2024) & (K Units)
Table 63. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2024-2029) & (K Units)
Table 64. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2024) & (K Units)
Table 67. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2024-2029) & (K Units)
Table 68. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2024) & (K Units)
Table 74. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2024-2029) & (K Units)
Table 75. China Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2024) & (K Units)
Table 76. China Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2024-2029) & (K Units)
Table 77. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2024) & (K Units)
Table 80. China Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2024-2029) & (K Units)
Table 81. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2024) & (K Units)
Table 84. Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2024-2029) & (K Units)
Table 85. Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2024) & (K Units)
Table 88. Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2024-2029) & (K Units)
Table 89. Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2018-2024) & (K Units)
Table 95. Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2024-2029) & (K Units)
Table 109. GlaxoSmithKline Company Information
Table 110. GlaxoSmithKline Description and Major Businesses
Table 111. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. GlaxoSmithKline Recent Developments
Table 114. Merck Company Information
Table 115. Merck Description and Major Businesses
Table 116. Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Merck Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Merck Recent Developments
Table 119. Panacea Biotec Company Information
Table 120. Panacea Biotec Description and Major Businesses
Table 121. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Panacea Biotec Recent Developments
Table 124. Pfizer Company Information
Table 125. Pfizer Description and Major Businesses
Table 126. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Pfizer Recent Developments
Table 129. Pnuvax Incorporated Company Information
Table 130. Pnuvax Incorporated Description and Major Businesses
Table 131. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Pnuvax Incorporated Recent Developments
Table 134. Serum Institute Company Information
Table 135. Serum Institute Description and Major Businesses
Table 136. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Serum Institute Recent Developments
Table 139. Shinogi Company Information
Table 140. Shinogi Description and Major Businesses
Table 141. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Shinogi Recent Developments
Table 144. Shenzhen Kangtai Biological Products Company Information
Table 145. Shenzhen Kangtai Biological Products Description and Major Businesses
Table 146. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Shenzhen Kangtai Biological Products Recent Developments
Table 149. SK Bioscience Company Information
Table 150. SK Bioscience Description and Major Businesses
Table 151. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. SK Bioscience Recent Developments
Table 154. Walvax Biotechnology Company Information
Table 155. Walvax Biotechnology Description and Major Businesses
Table 156. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Walvax Biotechnology Recent Developments
Table 159. Eli Lilly Company Information
Table 160. Eli Lilly Description and Major Businesses
Table 161. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Eli Lilly Recent Developments
Table 164. Abera Company Information
Table 165. Abera Description and Major Businesses
Table 166. Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Abera Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Abera Recent Developments
Table 169. Sanofi Company Information
Table 170. Sanofi Description and Major Businesses
Table 171. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Sanofi Recent Developments
Table 174. Genentech Company Information
Table 175. Genentech Description and Major Businesses
Table 176. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Genentech Recent Developments
Table 179. Key Raw Materials Lists
Table 180. Raw Materials Key Suppliers Lists
Table 181. Polyvalent Streptococcus Pneumococcal Vaccines Distributors List
Table 182. Polyvalent Streptococcus Pneumococcal Vaccines Customers List
Table 183. Polyvalent Streptococcus Pneumococcal Vaccines Market Trends
Table 184. Polyvalent Streptococcus Pneumococcal Vaccines Market Drivers
Table 185. Polyvalent Streptococcus Pneumococcal Vaccines Market Challenges
Table 186. Polyvalent Streptococcus Pneumococcal Vaccines Market Restraints
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Polyvalent Streptococcus Pneumococcal Vaccines Product Picture
Figure 2. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Share by Type in 2022 & 2029
Figure 4. 9-Valent Product Picture
Figure 5. 13-Valent Product Picture
Figure 6. 23-Valent Product Picture
Figure 7. Others Product Picture
Figure 8. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Community Clinics
Figure 12. Public Health Agencies
Figure 13. Others
Figure 14. Polyvalent Streptococcus Pneumococcal Vaccines Report Years Considered
Figure 15. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue 2018-2029 (US$ Million)
Figure 17. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Region (2018-2029)
Figure 19. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales 2018-2029 ((K Units)
Figure 20. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales YoY (2018-2029) & (K Units)
Figure 24. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Polyvalent Streptococcus Pneumococcal Vaccines Sales YoY (2018-2029) & (K Units)
Figure 26. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Polyvalent Streptococcus Pneumococcal Vaccines Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) Polyvalent Streptococcus Pneumococcal Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Polyvalent Streptococcus Pneumococcal Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines in the World: Market Share by Polyvalent Streptococcus Pneumococcal Vaccines Revenue in 2022
Figure 33. Global Polyvalent Streptococcus Pneumococcal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2029)
Figure 35. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2018-2029)
Figure 36. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2029)
Figure 37. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Country (2018-2029)
Figure 43. US & Canada Polyvalent Streptococcus Pneumococcal Vaccines Sales Share by Country (2018-2029)
Figure 44. U.S. Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2029)
Figure 47. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2018-2029)
Figure 48. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2029)
Figure 49. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application (2018-2029)
Figure 50. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Country (2018-2029)
Figure 51. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Share by Country (2018-2029)
Figure 52. Germany Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 53. France Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 57. China Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2029)
Figure 58. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2018-2029)
Figure 59. China Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2029)
Figure 60. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application (2018-2029)
Figure 61. Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2029)
Figure 62. Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2018-2029)
Figure 63. Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2029)
Figure 64. Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application (2018-2029)
Figure 65. Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Region (2018-2029)
Figure 66. Asia Polyvalent Streptococcus Pneumococcal Vaccines Sales Share by Region (2018-2029)
Figure 67. Japan Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 71. India Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales Share by Country (2018-2029)
Figure 78. Brazil Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Polyvalent Streptococcus Pneumococcal Vaccines Revenue (2018-2029) & (US$ Million)
Figure 83. Polyvalent Streptococcus Pneumococcal Vaccines Value Chain
Figure 84. Polyvalent Streptococcus Pneumococcal Vaccines Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries